Gonadotrophin-releasing hormone analogues for pain associated with endometriosis

Show simple item record

dc.contributor.author Brown, JA en
dc.contributor.author Pan, A en
dc.contributor.author Hart, R en
dc.date.accessioned 2011-11-14T20:44:24Z en
dc.date.issued 2010 en
dc.identifier.citation Cochrane Database of Systematic Reviews 114 pages Article number CD008475 2010 en
dc.identifier.issn 1469-493X en
dc.identifier.uri http://hdl.handle.net/2292/9039 en
dc.description.abstract BACKGROUND: Endometriosis is a common gynaecological condition, characterised by the presence of endometrial tissue in sites other than the uterine cavity (excluding adenomyosis) that frequently presents with pain. The gonadotrophin-releasing hormone analogues (GnRHas) comprise one intervention that has been offered for pain relief in pre-menopausal women. GnRHas can be administered intranasally, by subcutaneous, or intramuscular injection. They are thought to result in down regulation of the pituitary and induce a hypogonadotrophic hypogonadal state. OBJECTIVES: To determine the effectiveness and safety of GnRHas in the treatment of the painful symptoms associated with endometriosis. SEARCH STRATEGY: Electronic searches of the Cochrane Menstrual Disorders and Subfertility Group specialist register, CENTRAL, MEDLINE, EMBASE, PSYCInfo and CINAHL were conducted in April 2010 to identify relevant randomised controlled trials (RCTs). SELECTION CRITERIA: RCTs of GnRHas as treatment for pain associated with endometriosis versus no treatment, placebo, danazol, intra-uterine progestagens, or other GnRHas were included. Trials using add-back therapy, oral contraceptives, surgical intervention, GnRH antagonists or complementary therapies were excluded. DATA COLLECTION AND ANALYSIS: Quality assessment and data extraction were performed independently by two reviewers. The primary outcome was pain relief. Relative risk was used as the measure of effect for dichotomous data. For continuous data, mean differences or standardised mean differences were used. MAIN RESULTS: Forty one trials (n=4935 women) were included. The evidence suggested that GnRHas were more effective at symptom relief than no treatment/placebo. There was no statistically significant difference between GnRHas and danazol for dysmenorrhoea RR 0.98 (95%CI 0.92 to 1.04; P = 0.53). This equates to 3 fewer women per 1000 (95%CI 12 to 6) with symptomatic pain relief in the GnRHa group. More adverse events were reported in the GnRHa group. There was a benefit in overall resolution for GnRHas RR1.10 (95%CI 1.01 to 1.21, P=0.03) compared with danazol. There was no statistically significant difference in overall pain between GnRHas and levonorgestrel SMD -0.25 (95%CI -0.60 to 0.10, P=0.46). Evidence was limited on optimal dosage or duration of treatment for GnRHas. No route of administration appeared superior to another. AUTHORS' CONCLUSIONS: GnRHas appear to be more effective at relieving pain associated with endometriosis than no treatment/placebo. There was no evidence of a difference in pain relief between GnRHas and danazol although more adverse events reported in the GnRHa groups. There was no evidence of a difference in pain relief between GnRHas and levonorgestrel and no studies compared GnRHas with analgesics. en
dc.publisher John Wiley & Sons, Ltd. en
dc.relation.ispartofseries Cochrane Database of Systematic Reviews en
dc.rights Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. Details obtained from http://www.sherpa.ac.uk/romeo/issn/1469-493X/ en
dc.rights.uri https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm en
dc.rights.uri http://www.thecochranelibrary.com/view/0/PermissionsReprints.html en
dc.title Gonadotrophin-releasing hormone analogues for pain associated with endometriosis en
dc.type Journal Article en
dc.identifier.doi 10.1002/14651858.CD008475.pub2 en
pubs.issue 4 en
dc.rights.holder Copyright: 2010 The Cochrane Collaboration en
dc.identifier.pmid 10796530 en
pubs.declined 2016-08-17T15:14:23.744+1200 en
pubs.declined 2016-08-18T18:37:09.201+1200 en
pubs.declined 2016-08-19T15:11:55.975+1200 en
pubs.declined 2016-08-21T19:50:24.414+1200 en
pubs.declined 2016-08-22T15:13:24.875+1200 en
pubs.declined 2016-08-23T15:11:52.201+1200 en
pubs.declined 2016-08-24T15:15:00.132+1200 en
pubs.declined 2016-08-25T15:13:47.178+1200 en
pubs.declined 2016-08-26T15:20:31.766+1200 en
pubs.declined 2016-08-27T15:17:04.47+1200 en
pubs.declined 2016-08-28T15:18:25.549+1200 en
pubs.declined 2016-08-29T15:12:48.960+1200 en
pubs.declined 2016-08-30T15:12:23.466+1200 en
pubs.declined 2016-08-31T15:12:27.323+1200 en
pubs.declined 2016-09-01T15:14:05.530+1200 en
pubs.declined 2016-09-02T15:16:20.188+1200 en
pubs.declined 2016-09-03T15:25:45.78+1200 en
pubs.declined 2016-09-04T15:29:21.593+1200 en
pubs.declined 2016-09-05T15:36:22.219+1200 en
pubs.declined 2016-09-06T17:28:00.259+1200 en
pubs.declined 2016-11-22T17:02:41.927+1300 en
pubs.declined 2016-12-05T17:11:56.645+1300 en
pubs.declined 2016-12-17T17:18:15.706+1300 en
pubs.declined 2017-06-05T08:07:11.899+1200 en
pubs.declined 2017-06-25T17:44:25.216+1200 en
pubs.publication-status Published en
dc.rights.accessrights http://purl.org/eprint/accessRights/OpenAccess en
pubs.subtype Review en
pubs.elements-id 187954 en
pubs.org-id Medical and Health Sciences en
pubs.org-id School of Medicine en
pubs.org-id Obstetrics and Gynaecology en
pubs.number CD008475 en
pubs.record-created-at-source-date 2010-11-29 en
pubs.dimensions-id 10796530 en


Files in this item

Find Full text

This item appears in the following Collection(s)

Show simple item record

Share

Search ResearchSpace


Browse

Statistics